pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›calendar
  3. ›approval
approval
save

BUTRANS (BUPRENORPHINE) — FDA approval

September 18, 2018BUTRANSupdated 5mo ago
community read0 votes

Sponsor: PURDUE PHARMA LP. Form: FILM, EXTENDED RELEASE. Route: TRANSDERMAL

view source ↗
Data sources
fda approvals
last refreshed 5mo ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

drug timeline · 8

  • approvalBUTRANS (BUPRENORPHINE) — FDA approvalDec 22, 2025 · 283d ago
  • approvalBUTRANS (BUPRENORPHINE) — FDA approvalOct 31, 2024 · 700d ago
  • approvalBUTRANS (BUPRENORPHINE) — FDA approvalDec 15, 2023 · 1021d ago
  • approvalBUTRANS (BUPRENORPHINE) — FDA approvalJun 17, 2022 · 1567d ago
  • approvalBUTRANS (BUPRENORPHINE) — FDA approvalMar 4, 2021 · 2037d ago
  • approvalBUTRANS (BUPRENORPHINE) — FDA approvalOct 7, 2019 · 2551d ago
  • approvalBUTRANS (BUPRENORPHINE) — FDA approvalSep 18, 2018 · 2935d ago
  • approvalBUTRANS (BUPRENORPHINE) — FDA approvalOct 13, 2017 · 3275d ago

same company · ±60 days · 6

  • approvalBUTRANS: BUTRANS (BUPRENORPHINE) — FDA approvalSep 18, 2018
  • approvalKapanol: MS CONTIN (MORPHINE SULFATE) — FDA approvalSep 18, 2018
  • approvalKapanol: MS CONTIN (MORPHINE SULFATE) — FDA approvalSep 18, 2018
  • approvalOXYCODONE HYDROCHLORIDE: OXYCONTIN (OXYCODONE HYDROCHLORIDE) — FDA approvalSep 18, 2018
  • approvalOXYCODONE HYDROCHLORIDE: OXYCONTIN (OXYCODONE HYDROCHLORIDE) — FDA approvalSep 18, 2018
  • approvalOXYCODONE HYDROCHLORIDE: OXYCONTIN (OXYCODONE HYDROCHLORIDE) — FDA approvalSep 26, 2018

🐶 often sniffed alongside

top 8
  • tagApproval1,664 co-mentions · 579 sources
  • drugSUBLOCADE1,368 co-mentions · 584 sources
  • drugBRIXADI1,296 co-mentions · 584 sources
  • drugbuprenorphine1,291 co-mentions · 584 sources
  • drugbuprenorphine ER1,291 co-mentions · 584 sources
  • drugSUBOXONE1,276 co-mentions · 528 sources
  • drugBUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE1,236 co-mentions · 528 sources
  • drugBUPRENORPHINE HYDROCHLORIDE1,209 co-mentions · 528 sources

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?